Abstract
Purpose
To describe the risk factors, clinical features and management outcomes of ocular surface squamous neoplasia (OSSN) with 360° of limbal involvement (360-OSSN) and compare with segmental limbal involvement (SL-OSSN).
Methods
Retrospective comparative study of 360-OSSN vs SL-OSSN. All 360-OSSN and every 10th patient with SL-OSSN during the study period (2012–2020) were included. Lesions with uncertain diagnosis were excluded.
Results
Of 1250 patients diagnosed with OSSN during the study period, 30 (2%) had 360-OSSN. A total of 100 patients of OSSN with SL-OSSN were included for comparison. 360-OSSN patients more often had longer duration of symptoms (mean, 17 vs 8 months; p, 0.003), prior misdiagnosis (17% vs 6%, p, 0.13) and prior intervention (47% vs 13%; p, 0.0002) than patients with SL-OSSN. 360-OSSN had higher incidence of scleral fixity (57% vs 16%; p < 0.0001), corneal/scleral melt (17% vs 0%; p, 0.0005), intraocular tumor extension (17% vs 0%; p, 0.003), orbital tumor extension (33% vs 1%; p < 0.0001), and advanced T stage at presentation (Tis: 37% vs 76%, T1: 0% vs 15%; T2: 7% vs 4%; T3: 27% vs 4%; T4: 30% vs 1%; p < 0.001). Over a mean follow-up of 14 months, lymph node metastasis (8% vs 0%; p, 0.05) and distant metastasis (4% vs 0%; p, 0.23) were more common in 360-OSSN group compared to SL-OSSN group.
Conclusion
Risk factors of 360-OSSN include prolonged symptoms, prior misdiagnosis and prior intervention. It represents an advanced form of disease with propensity for corneo-scleral melt and invasive disease which requires aggressive management.
Similar content being viewed by others
References
Gichuhi S, Macharia E, Kabiru J et al (2015) Clinical presentation of ocular surface squamous neoplasia in Kenya. JAMA Ophthalmol 133(11):1305–1313
Zarei-Ghanavati S, Alizadeh R, Deng SX (2014) Topical interferon alpha-2b for treatment of noninvasive ocular surface squamous neoplasia with 360° limbal involvement. J Ophthalmic Vis Res 9(4):423–426
Kalamkar C, Radke N, Mukherjee A, Radke S (2016) Xeroderma pigmentosum with bilateral ocular surface squamous neoplasia and review of the literature. BMJ Case Rep. bcr2016215364.
Kumar DA, Agarwal A (2018) Giant ocular surface squamous neoplasia wrapping whole cornea. Eye Contact Lens 44:S358–S360
Patel H, Jeang LJ, Shah A, Espana EM, Margo CE (2018) Widespread ocular surface squamous neoplasia treated with topical interferon alpha-2b. Ocul Oncol Pathol 4(5):298–303
Mohamed-Noriega K, Treviño-Herrera AB, Olvera-Barrios A, Morales-Wong F, Mohamed-Hamsho J (2019) Resolution of giant ocular surface squamous neoplasia with topical 5-fuorouracil 1. SAGE Open Med Case Rep. 2019 7:2050313X19843392
Cicinelli MV, Marchese A, Bandello F, Modorati G (2018) Clinical management of ocular surface squamous neoplasia: a review of the current evidence. Ophthalmol Ther 7(2):247–262
Nanji AA, Sayyad FE, Galor A et al (2015) High-resolution optical coherence tomography as an adjunctive tool in the diagnosis of corneal and conjunctival pathology. Ocul Surf 13:226–235
Conway RM, Graue GF, Pelayes DE et al (2017) Conjunctival Carcinoma. American Joint Committee on Cancer (AJCC). AJCC Cancer Staging Manual, 8th edn. Springer, New York
Kapoor AG, Vempuluru VS, Laghimshetty S et al (2021) Ocular surface squamous neoplasia with coexistent microbial keratitis: incidence, risk factors, clinical features, microbiological profile, and treatment outcome. Cornea. https://doi.org/10.1097/ICO.0000000000002809
Kaliki S, Mohammad FA, Tahiliani P, Sangwan VS (2017) Concomitant simple limbal epithelial transplantation after surgical excision of ocular surface squamous neoplasia. Am J Ophthalmol 174:68–75
Funding
Support provided by The Operation Eyesight Universal Institute for Eye Cancer (SK) and Hyderabad Eye Research Foundation (SK), Hyderabad, India. The funders had no role in the preparation, review or approval of the manuscript.
Author information
Authors and Affiliations
Contributions
SK contributed to the study conception and design. Material preparation, data collection and analysis were performed by VSV, NG, MP, and AM. The first draft of the manuscript was written by VSV and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of LV Prasad Eye Institute.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Consent to publish
The authors affirm that human research participants provided informed consent for publication of the images in Figs. 1, 2, and 3
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Vempuluru, V.S., Ghose, N., Pattnaik, M. et al. Ocular surface squamous neoplasia with 360° limbal involvement: a study of 130 patients. Int Ophthalmol 43, 609–618 (2023). https://doi.org/10.1007/s10792-022-02463-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-022-02463-7